| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.2 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |